about
Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approachProstate involvement during sexually transmitted infections as measured by prostate-specific antigen concentrationDoes PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10 ng/mL?Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First BiopsyThe implementation of screening for prostate cancer.Screening for prostate cancer: a controversy or fact.Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection.Chikungunya Virus Infection and Acute Elevation of Serum Prostate-Specific Antigen.Pathological Outcome following Radical Prostatectomy in Men with Prostate Specific Antigen Greater than 10 ng/ml and Histologically Favorable Risk Prostate Cancer.Chronic prostatitis does not influence urinary PCA3 score.Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set.Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence?Incidental diagnosis of a PSA-negative prostate cancer by 18FDG PET/CT in a patient with hypopharyngeal cancer.Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study.
P2860
Q33770342-3B19DBC5-8217-4F88-A226-8523A727F7DEQ35287769-3C468346-E8EA-444E-B6A4-43352550A1F9Q36575823-B74FA89C-44A5-4222-A1F5-06A45E326FFCQ37014809-F8324632-784D-4586-B466-EFE243C31DCBQ37777325-1048A0EF-68B1-4596-8ED1-595FEDBE0A84Q37803538-F4BE2809-A1CD-4E2C-B566-EF3B7AA82DB0Q38383052-38413546-C6A6-454B-BAAF-60B0B8BED5B9Q40147630-7A9FCC07-6526-44EF-A149-6874CDF061ADQ41095691-EEE1F49F-E184-45A3-880F-04BFAA468F0CQ50529277-10A19925-CCF6-4D5A-A41E-5CCED82EDC2CQ52624735-8AB335D7-95B1-460C-B7AD-68CDDBF0BDFCQ53372753-2BE4202E-8433-49DE-BEBD-890CDDB4F518Q53495411-77E4EC85-E6A1-4624-90F4-5058C455F3D3Q54945681-1B67B44C-C52C-4DA4-8958-02AF6EB11694
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Prostatitis and serum prostate-specific antigen.
@ast
Prostatitis and serum prostate-specific antigen.
@en
type
label
Prostatitis and serum prostate-specific antigen.
@ast
Prostatitis and serum prostate-specific antigen.
@en
prefLabel
Prostatitis and serum prostate-specific antigen.
@ast
Prostatitis and serum prostate-specific antigen.
@en
P1476
Prostatitis and serum prostate-specific antigen.
@en
P2093
Christopher M Wilson
Puneet Sindhwani
P2888
P304
P356
10.1007/S11934-005-0029-Y
P577
2005-07-01T00:00:00Z